At this BASG meeting, we will inform you about current and future developments in the field of pharmacovigilance in connection with various aspects of marketing authorisation and the associated life cycle of human medicinal products.
Contents
- Cutting-edge topics in both regulatory and medical terms
- Presentations from the area of individual case reports
- Interesting topics from the Pharmacovigilance Risk Assessment Committee
- Exchange of experience and discussion
Target group
- Employees of pharmacovigilance and authorisation departments
- Employees of consulting companies in the pharmaceutical industry
Language
German
Registration information
Please register by 20.11.2024 at the latest.
This event will be held as a hybrid event (participation online or in person on site possible).
Technical director and lecturer
Dr Jan Neuhauser
Institute for Assessment and Analysis
Medical Market Surveillance Business Unit, AGES GmbH